Literature DB >> 11705144

Congenital nasolacrimal duct obstruction.

R M Robb1.   

Abstract

Congenital nasolacrimal duct obstruction is a common problem among infants. Its incidence and natural course are reviewed. Probing techniques and various back-up procedures for failed probings are discussed. Additional suggestions are made about the management of lacrimal duct obstruction with congenital cacryocystocele and nasal dacryocele.

Entities:  

Mesh：

Year:  2001        PMID： 11705144     DOI： 10.1016/s0896-1549(05)70242-x

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN： 0896-1549


  5 in total

1.  The course of epiphora after failure of silicone intubation for congenital nasolacrimal duct obstruction.

Authors:  Yanir Kassif; Uri Rehany; Michal David; Anna Popko; Shimon Rumelt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-09       Impact factor: 3.117

2.  Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.

Authors:  Piero Steindler; Enrico Mantovani; Carlo Incorvaia; Francesco Parmeggiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-24       Impact factor: 3.117

3.  The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.

Authors:  Omer Karti; Eyyup Karahan; Durgul Acan; Tuncay Kusbeci
Journal:  Int Ophthalmol       Date:  2016-03-07       Impact factor: 2.031

4.  Factors affecting treatment outcome in congenital nasolacrimal duct obstruction: A retrospective analysis from South India.

Authors:  Sahil Bhandari; Sabyasachi Sengupta; Dayakar Yadalla; Jayagayathri Rajagopalan; Girish Bharat Velis; Deepti Talele; Sameer Kushwaha
Journal:  Indian J Ophthalmol       Date:  2015-10       Impact factor: 1.848

Review 5.  Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Paolo Nucci; Massimiliano Serafino; Giuseppe Giannaccare; Andrea Lembo; Carlo Enrico Traverso
Journal:  Diseases       Date:  2018-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.